145 related articles for article (PubMed ID: 38127922)
21. Influenza H3 hemagglutinin vaccine with scrambled immunodominant epitopes elicits antibodies directed toward immunosubdominant head epitopes.
Chiba S; Kong H; Neumann G; Kawaoka Y
mBio; 2023 Aug; 14(4):e0062223. PubMed ID: 37466314
[TBL] [Abstract][Full Text] [Related]
22. Broadly Reactive H2 Hemagglutinin Vaccines Elicit Cross-Reactive Antibodies in Ferrets Preimmune to Seasonal Influenza A Viruses.
Reneer ZB; Skarlupka AL; Jamieson PJ; Ross TM
mSphere; 2021 Mar; 6(2):. PubMed ID: 33692193
[TBL] [Abstract][Full Text] [Related]
23. Cross-protective potential of a novel monoclonal antibody directed against antigenic site B of the hemagglutinin of influenza A viruses.
Yoshida R; Igarashi M; Ozaki H; Kishida N; Tomabechi D; Kida H; Ito K; Takada A
PLoS Pathog; 2009 Mar; 5(3):e1000350. PubMed ID: 19300497
[TBL] [Abstract][Full Text] [Related]
24. Antibody recognition of the pandemic H1N1 Influenza virus hemagglutinin receptor binding site.
Hong M; Lee PS; Hoffman RM; Zhu X; Krause JC; Laursen NS; Yoon SI; Song L; Tussey L; Crowe JE; Ward AB; Wilson IA
J Virol; 2013 Nov; 87(22):12471-80. PubMed ID: 24027321
[TBL] [Abstract][Full Text] [Related]
25. Mapping of a Novel H3-Specific Broadly Neutralizing Monoclonal Antibody Targeting the Hemagglutinin Globular Head Isolated from an Elite Influenza Virus-Immunized Donor Exhibiting Serological Breadth.
Qiu Y; Stegalkina S; Zhang J; Boudanova E; Park A; Zhou Y; Prabakaran P; Pougatcheva S; Ustyugova IV; Vogel TU; Mundle ST; Oomen R; Delagrave S; Ross TM; Kleanthous H; Qiu H
J Virol; 2020 Feb; 94(6):. PubMed ID: 31826999
[TBL] [Abstract][Full Text] [Related]
26. Differential neutralization efficiency of hemagglutinin epitopes, antibody interference, and the design of influenza vaccines.
Ndifon W; Wingreen NS; Levin SA
Proc Natl Acad Sci U S A; 2009 May; 106(21):8701-6. PubMed ID: 19439657
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of influenza virus A/H3N2 and B vaccines on the basis of cross-reactivity of postvaccination human serum antibodies against influenza viruses A/H3N2 and B isolated in MDCK cells and embryonated hen eggs.
Kishida N; Fujisaki S; Yokoyama M; Sato H; Saito R; Ikematsu H; Xu H; Takashita E; Tashiro M; Takao S; Yano T; Suga T; Kawakami C; Yamamoto M; Kajiyama K; Saito H; Shimada S; Watanabe S; Aoki S; Taira K; Kon M; Lin JH; Odagiri T
Clin Vaccine Immunol; 2012 Jun; 19(6):897-908. PubMed ID: 22492743
[TBL] [Abstract][Full Text] [Related]
28. Identification of human vaccinees that possess antibodies targeting the egg-adapted hemagglutinin receptor binding site of an H1N1 influenza vaccine strain.
Garretson TA; Petrie JG; Martin ET; Monto AS; Hensley SE
Vaccine; 2018 Jun; 36(28):4095-4101. PubMed ID: 29861178
[TBL] [Abstract][Full Text] [Related]
29. H1 Hemagglutinin Priming Provides Long-Lasting Heterosubtypic Immunity against H5N1 Challenge in the Mouse Model.
Carreño JM; Strohmeier S; Kirkpatrick Roubidoux E; Hai R; Palese P; Krammer F
mBio; 2020 Dec; 11(6):. PubMed ID: 33323511
[TBL] [Abstract][Full Text] [Related]
30. Conserved neutralizing epitope at globular head of hemagglutinin in H3N2 influenza viruses.
Iba Y; Fujii Y; Ohshima N; Sumida T; Kubota-Koketsu R; Ikeda M; Wakiyama M; Shirouzu M; Okada J; Okuno Y; Kurosawa Y; Yokoyama S
J Virol; 2014 Jul; 88(13):7130-44. PubMed ID: 24719430
[TBL] [Abstract][Full Text] [Related]
31. Neutralizing Antibody Responses to Homologous and Heterologous H1 and H3 Influenza A Strains After Vaccination With Inactivated Trivalent Influenza Vaccine Vary With Age and Prior-year Vaccination.
Wang W; Chen Q; Ford-Siltz LA; Katzelnick LC; Parra GI; Song HS; Vassell R; Weiss CD
Clin Infect Dis; 2019 May; 68(12):2067-2078. PubMed ID: 30256912
[TBL] [Abstract][Full Text] [Related]
32. Conserved stem fragment from H3 influenza hemagglutinin elicits cross-clade neutralizing antibodies through stalk-targeted blocking of conformational change during membrane fusion.
Gong X; Yin H; Shi Y; Guan S; He X; Yang L; Yu Y; Kuai Z; Jiang C; Kong W; Wang S; Shan Y
Immunol Lett; 2016 Apr; 172():11-20. PubMed ID: 26875772
[TBL] [Abstract][Full Text] [Related]
33. Development of a Pan-H1 Influenza Vaccine.
Darricarrère N; Pougatcheva S; Duan X; Rudicell RS; Chou TH; DiNapoli J; Ross TM; Alefantis T; Vogel TU; Kleanthous H; Wei CJ; Nabel GJ
J Virol; 2018 Nov; 92(22):. PubMed ID: 30185594
[TBL] [Abstract][Full Text] [Related]
34. Standard trivalent influenza virus protein vaccination does not prime antibody-dependent cellular cytotoxicity in macaques.
Jegaskanda S; Amarasena TH; Laurie KL; Tan HX; Butler J; Parsons MS; Alcantara S; Petravic J; Davenport MP; Hurt AC; Reading PC; Kent SJ
J Virol; 2013 Dec; 87(24):13706-18. PubMed ID: 24109221
[TBL] [Abstract][Full Text] [Related]
35. Flow cytometry reveals that H5N1 vaccination elicits cross-reactive stem-directed antibodies from multiple Ig heavy-chain lineages.
Whittle JR; Wheatley AK; Wu L; Lingwood D; Kanekiyo M; Ma SS; Narpala SR; Yassine HM; Frank GM; Yewdell JW; Ledgerwood JE; Wei CJ; McDermott AB; Graham BS; Koup RA; Nabel GJ
J Virol; 2014 Apr; 88(8):4047-57. PubMed ID: 24501410
[TBL] [Abstract][Full Text] [Related]
36. Structure-Guided Molecular Grafting of a Complex Broadly Neutralizing Viral Epitope.
Bajic G; Maron MJ; Caradonna TM; Tian M; Mermelstein A; Fera D; Kelsoe G; Kuraoka M; Schmidt AG
ACS Infect Dis; 2020 May; 6(5):1182-1191. PubMed ID: 32267676
[TBL] [Abstract][Full Text] [Related]
37. A Computationally Optimized Broadly Reactive Antigen Subtype-Specific Influenza Vaccine Strategy Elicits Unique Potent Broadly Neutralizing Antibodies against Hemagglutinin.
Sautto GA; Kirchenbaum GA; Abreu RB; Ecker JW; Pierce SR; Kleanthous H; Ross TM
J Immunol; 2020 Jan; 204(2):375-385. PubMed ID: 31811019
[TBL] [Abstract][Full Text] [Related]
38. A virus-like particle vaccination strategy expands its tolerance to H3N2 antigenic drift by enhancing neutralizing antibodies against hemagglutinin stalk.
Yang JR; Cheng CY; Chen CY; Lin CH; Kuo CY; Huang HY; Wu FT; Yang YC; Wu CY; Liu MT; Hsiao PW
Antiviral Res; 2017 Apr; 140():62-75. PubMed ID: 28093338
[TBL] [Abstract][Full Text] [Related]
39. Influenza human monoclonal antibody 1F1 interacts with three major antigenic sites and residues mediating human receptor specificity in H1N1 viruses.
Tsibane T; Ekiert DC; Krause JC; Martinez O; Crowe JE; Wilson IA; Basler CF
PLoS Pathog; 2012; 8(12):e1003067. PubMed ID: 23236279
[TBL] [Abstract][Full Text] [Related]
40. Broadly protective monoclonal antibodies against H3 influenza viruses following sequential immunization with different hemagglutinins.
Wang TT; Tan GS; Hai R; Pica N; Petersen E; Moran TM; Palese P
PLoS Pathog; 2010 Feb; 6(2):e1000796. PubMed ID: 20195520
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
